Literature DB >> 12172748

Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis.

F-C Bange1, E C Böttger.   

Abstract

In order to improve the recovery of mycobacteria from patients with cystic fibrosis, the present study evaluated a two-step decontamination procedure for clinical specimens. A total of 920 specimens obtained from 239 patients with cystic fibrosis were treated initially with N-acetyl-L-cysteine/sodium hydroxide. Of these specimens, 31 (3.3%) showed mycobacterial growth and 415 (45.1%) remained contaminated. Contaminated specimens were then subjected to a second round of decontamination, using a combination of N-acetyl-L-cysteine/sodium hydroxide and oxalic acid. Following this second decontamination, the number of specimens overgrown by microorganisms other than mycobacteria was reduced to 7.3%, and an additional 10 specimens positive for mycobacteria were found. The results suggest this two-step protocol could improve the recovery of mycobacteria from heavily contaminated specimens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172748     DOI: 10.1007/s10096-002-0760-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

Review 1.  Non-tuberculous mycobacteria in cystic fibrosis.

Authors:  Uta G Hill; R Andres Floto; Charles S Haworth
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Comparison of culture methods for isolation of nontuberculous mycobacteria from surface waters.

Authors:  Nicolas Radomski; Emmanuelle Cambau; Laurent Moulin; Sophie Haenn; Régis Moilleron; Françoise S Lucas
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

4.  Evaluation of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Samples from Patients with Cystic Fibrosis in the United States.

Authors:  Rongpong Plongla; Clair L Preece; John D Perry; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2017-02-22       Impact factor: 5.948

5.  Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.

Authors:  Paul Saleeb; Kenneth N Olivier
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

6.  Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.

Authors:  Kai Rüger; Annegret Hampel; Sandra Billig; Nadine Rücker; Sebastian Suerbaum; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

7.  Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis.

Authors:  Ian Eltringham; Julie Pickering; Helen Gough; Clair L Preece; John D Perry
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

8.  Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.

Authors:  Kelly M Pennington; Ann Vu; Douglas Challener; Christina G Rivera; F N U Shweta; John D Zeuli; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-05-08

Review 9.  Nontuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Kate Skolnik; Gordon Kirkpatrick; Bradley S Quon
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-22

10.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.

Authors:  R Andres Floto; Kenneth N Olivier; Lisa Saiman; Charles L Daley; Jean-Louis Herrmann; Jerry A Nick; Peadar G Noone; Diana Bilton; Paul Corris; Ronald L Gibson; Sarah E Hempstead; Karsten Koetz; Kathryn A Sabadosa; Isabelle Sermet-Gaudelus; Alan R Smyth; Jakko van Ingen; Richard J Wallace; Kevin L Winthrop; Bruce C Marshall; Charles S Haworth
Journal:  Thorax       Date:  2016-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.